Aurobindo Pharma Ltd. NSE: AUROPHARMA | BSE: 524804

Value Stock, Under Radar

Download real time

1082.45 24.45 (2.31%)

32.01% Fall from 52W High

1.6M NSE+BSE Volume

NSE 11 Apr, 2025 3:31 PM (IST)

0.8

Beta 1Year

Very Low volatility

US FDA Approval

Aurobindo Pharma gets US FDA approval to produce Rivaroxaban tablets with a market size of $8.5 bn See details

Aurobindo Pharma Ltd. RSI, Moving Averages, Technical Analysis MACD, MFI, Stochastic and Candlesticks

Aurobindo Pharma technical analysis - SMA, EMA, Price Change analysis, 52 Week high low, Beta and volume delivery analysis